Contravisory Investment Management, Inc. Astrazeneca PLC Transaction History

Contravisory Investment Management, Inc.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 10, 2023	BUY	$64.85 - $71.7 $8,819 - $9,751	136 Added 5.9%	2,441 $165,000
Q2 2023 Jul 12, 2023	BUY	$69.91 - $75.81 $61,241 - $66,409	876 Added 61.3%	2,305 $164,000
Q1 2023 Apr 12, 2023	BUY	$63.15 - $71.6 $9,030 - $10,238	143 Added 11.12%	1,429 $99,000
Q4 2022 Jan 13, 2023	BUY	$54.21 - $70.44 $69,714 - $90,585	1,286 New	1,286 $0
Q1 2021 Apr 14, 2021	SELL	$47.16 - $54.44 $61,968 - $71,534	-1,314 Closed	0 $0
Q4 2020 Jan 13, 2021	BUY	$48.52 - $58.02 $1,649 - $1,972	34 Added 2.66%	1,314 $66,000
Q2 2020 Jul 09, 2020	SELL	$43.1 - $55.31 $1,422 - $1,825	-33 Reduced 2.51%	1,280 $69,000
Q1 2020 Apr 09, 2020	BUY	$37.79 - $51.33 $906 - $1,231	24 Added 1.86%	1,313 $59,000
Q4 2019 Jan 09, 2020	SELL	$42.46 - $50.46 $721 - $857	-17 Reduced 1.3%	1,289 $64,000
Q3 2019 Oct 07, 2019	BUY	$40.12 - $45.47 $1,323 - $1,500	33 Added 2.59%	1,306 $58,000
Q1 2019 Apr 08, 2019	BUY	$35.49 - $43.02 $45,178 - $54,764	1,273 New	1,273 $51,000
Q1 2018 Apr 09, 2018	SELL	$32.97 - $36.63 $626 - $695	-19 Closed	0 $0
Q4 2017 Jan 18, 2018	BUY	$32.09 - $34.78 $609 - $660	19	19 $1,000

1,339

478M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $224B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Contravisory Investment Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Contravisory Investment Management, Inc. with notifications on news.